TrialBMC oral health2023

A randomized phase II study of acyclovir for the prevention of chemotherapy-induced oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation.

Junshik Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.